BBCMF (Lir Life Sciences) Intangible Assets: $0.07 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Intangible Assets?

Lir Life Sciences BBCMF 15 Intangible Assets is $0.07 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Lir Life Sciences's intangible assets for the quarter that ended in Jan. 2026 was $0.07 Mil.

Lir Life Sciences  (OTCPK:BBCMF) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.

Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.

Lir Life Sciences Intangible Assets Related Terms

Lir Life Sciences Intangible Assets Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Intangible Assets Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Intangible Assets
0.00 0.00

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Intangible Assets Get a 7-Day Free Trial 0.00 0.00 0.08 0.00 0.07
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Intangible Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.

Frequently Asked Questions Learn more about Intangible Assets →
What does a Intangible Assets of $0.07 Mil mean?
Lir Life Sciences (BBCMF) has a Intangible Assets of $0.07 Mil as of Jan. 2026. Intangible assets include patents, goodwill and trade secrets. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Intangible Assets too high?
Lir Life Sciences' current Intangible Assets is $0.07 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Intangible Assets compare to VRTX and REGN?
Lir Life Sciences' Intangible Assets of $0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intangible Assets for a Biotechnology company?
A good Intangible Assets depends on the Biotechnology industry context. However, Intangible Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intangible Assets mean?
A high Intangible Assets can signal that a stock is expensive relative to its fundamentals. Intangible assets include patents, goodwill and trade secrets. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Intangible Assets is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Intangible Assets of $0.07 Mil. The current Intangible Assets is $0.07 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intangible Assets calculated?
Intangible Assets is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Intangible Assets is $0.07 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Intangible Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price